nicotine has been researched along with n-oleoylethanolamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldberg, SR; Luchicchi, A; Melis, M; Muntoni, AL; Pillolla, G; Pistis, M; Yasar, S | 1 |
| Buczynski, MW; Parsons, LH; Polis, IY | 1 |
| Melis, M; Pistis, M | 1 |
1 review(s) available for nicotine and n-oleoylethanolamine
| Article | Year |
|---|---|
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: therapeutic perspectives.
Topics: Amides; Animals; Endocannabinoids; Ethanolamines; Humans; Molecular Targeted Therapy; Nervous System Diseases; Nicotine; Oleic Acids; Palmitic Acids; PPAR alpha; Receptors, Nicotinic; Tobacco Use Disorder | 2014 |
2 other study(ies) available for nicotine and n-oleoylethanolamine
| Article | Year |
|---|---|
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
Topics: Amides; Amidohydrolases; Animals; Appetite Depressants; Arachidonic Acids; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Dopamine; Endocannabinoids; Enzyme Activation; Enzyme Inhibitors; Ethanolamines; Injections, Intraventricular; Lipoxygenase Inhibitors; Male; Neurons; Nicotine; Oleic Acids; Organ Culture Techniques; Palmitic Acids; Patch-Clamp Techniques; Piperidines; PPAR alpha; Protein-Tyrosine Kinases; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Rimonabant; Ventral Tegmental Area | 2008 |
The volitional nature of nicotine exposure alters anandamide and oleoylethanolamide levels in the ventral tegmental area.
Topics: Animals; Arachidonic Acids; Choice Behavior; Endocannabinoids; Male; Nicotine; Oleic Acids; Polyunsaturated Alkamides; Rats; Rats, Wistar; Self Administration; Ventral Tegmental Area | 2013 |